NAMS
NewAmsterdam Pharma Company NV
$21.93
+3.54% (+$0.75)
Volume
2.31M
52W High
$42.21
52W Low
$21.02
Market Cap
$3.22B
What to Watch This Quarter
Based on historical dataConsensus EPS
-$0.50
Whisper EPS
-$0.50
0.4% above consensus
Last Quarter
-$0.52
Current Streak
1 Miss
Avg Surprise (4Q)
+9.80%
Next Earnings Report
Reports in 46 days
Price Chart
EPS History: Consensus vs Actual
Last 11 quartersPrice Movement Around Earnings
Q2 2026
Aug 5, 2026
1-Day:
+0.91%
5-Day:
+2.04%
Q1 2026
May 14, 2026
1-Day:
-3.90%
5-Day:
-8.57%
Q1 2026
May 7, 2026
1-Day:
+11.13%
5-Day:
+11.59%
Q4 2025
Mar 4, 2026
1-Day:
-3.34%
5-Day:
-1.31%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'25 | $32,000 | -99.8% | -84.4% | -10,000.0% | -$74.9M |
| Q3'25 | $348,000 | -98.8% | 100.0% | -10,000.0% | -$72.0M |
| Q2'25 | $19.1M | +740.1% | 100.0% | -186.1% | -$17.4M |
| Q1'25 | $3.0M | +112.6% | 100.0% | -2,314.5% | -$39.5M |
| Q4'24 | $12.8M | +1,490.5% | 100.0% | -338.5% | -$92.2M |
| Q3'24 | $29.1M | +889.8% | 100.0% | -85.9% | -$16.6M |
| Q2'24 | $2.3M | +32.7% | 100.0% | -2,306.9% | -$39.0M |
| Q1'24 | $1.4M | -83.8% | 100.0% | -3,960.2% | -$93.8M |
Company Information
Symbol
NAMS
Company
NewAmsterdam Pharma Company NV
Market Cap
$3.22B
Next Earnings
Nov 4, 2026